|
IKNA
|
Ikena Oncology, Inc.
|
US
|
NASDAQ
|
|
ILMN
|
Illumina, Inc.
|
US
|
NASDAQ
|
|
IMNN
|
Imunon, Inc.
|
US
|
NASDAQ
|
|
IMRX
|
Immuneering Corporation
|
US
|
NASDAQ
|
|
INKT
|
MiNK Therapeutics, Inc.
|
US
|
NASDAQ
|
|
INZY
|
Inozyme Pharma, Inc.
|
US
|
NASDAQ
|
|
IPSC
|
Century Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IVA
|
Inventiva S.A.
|
US
|
NASDAQ
|
|
IVVD
|
Invivyd, Inc.
|
US
|
NASDAQ
|
|
JNCE
|
Jounce Therapeutics, Inc.
|
US
|
NASDAQ
|
|
JSPR
|
Jasper Therapeutics, Inc
|
US
|
NASDAQ
|
|
KLDO
|
Kaleido Biosciences, Inc.
|
US
|
NASDAQ
|
|
KRON
|
Kronos Bio, Inc.
|
US
|
NASDAQ
|
|
LBPH
|
Longboard Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
LCTX
|
Lineage Cell Therapeutics, Inc.
|
US
|
AMEX
|
|
LFVN
|
Lifevantage Corporation
|
US
|
NASDAQ
|
|
LGVN
|
Longeveron Inc.
|
US
|
NASDAQ
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
US
|
NASDAQ
|
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ME
|
23andMe Holding Co.
|
US
|
NASDAQ
|